Delivery Order SPE2DB22D1106-SPE2DB24FEVQ7
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Loperamide 2 mg capsules (100-count units) valued at $16,158.96. This firm fixed price, competitively awarded delivery order represents a non-set-aside procurement executed under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The place of...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Loperamide Hydrochloride, an anti-diarrheal pharmaceutical. This competitively awarded, firm fixed-price delivery order has a ceiling value of $31.7K and an ultimate completion date of October 10, 2025. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and carries no set-aside designation....
- The U.S. Defense Logistics Agency (DLA) awarded a $7,022.60 delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division to provide pharmaceutical products and medical supplies. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between Amerisourcebergen and DLA Troop Support Medical, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of medical commodities to the Department of...
- This federal contract award, valued at $28,113.75, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract is a Delivery Order placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, which has a ceiling value of up to $999,999,999.00 through December 31, 2025. This single-award IDC...
- This federal contract award, valued at $1,456.19, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, covers the procurement of 36,000 units of a medical capsule product. The IDC, valued at $999,999,999 and running through November 2026, serves as a primary vehicle for...
- The U.S. government's Defense Logistics Agency (DLA) has awarded a $17,401.91 Firm Fixed Price delivery order contract to Amerisourcebergen Drug Corporation's Corporate Office Division. This contract is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical supplies, including specialty, brand...
- The U.S. government awarded a $11,029.41 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is for the provision of a range of prescription medications, over-the-counter drugs, and medical supplies to support the Department of Defense (DoD) and other government agencies. This order is a part of Amerisourcebergen's larger...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at up to $41,250.60, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA. The IDC, worth up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of...
- The U.S. government awarded a Delivery Order contract worth $1,672.37 to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract, issued by the Defense Logistics Agency (DLA) Troop Support Medical, is for the provision of a range of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as critical care materials such as syringes, vials, and test kits. This Delivery...
- This federal contract award, valued at $7,798.47, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of pharmaceutical products and medical supplies, including prescription medications, over-the-counter drugs, and critical care materials such as syringes and test kits. Amerisourcebergen, a major supplier of pharmaceutical products to the U.S. government, holds a larger Indefinite...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEVQ7Delivery Order
This federal contract award, with a value of $7,715.41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the delivery of loperamide 2 mg capsules, a common over-the-counter medication. The award is a delivery order placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, has extensive experience fulfilling government contracts for a variety of medications and medical supplies. The company's expertise in pharmaceutical logistics allows it to efficiently manage the complex distribution of critical medical products to military treatment programs and other government facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.7k | 6/6/24 |